Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic measures in the solid-organ recipient before transplantation.

R K Avery1, P Ljungman

  • 1Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA. averyr@ccf.org

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 5, 2001
PubMed
Summary

Pretransplant screening and updated immunizations are crucial for preventing infections in solid-organ transplant recipients. Early vaccination, including pneumococcal, influenza, and hepatitis B, is vital before transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

Leukemia·2026
Same author

Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).

Bone marrow transplantation·2023
Same author

Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.

Transplantation and cellular therapy·2022
Same author

Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study.

Bone marrow transplantation·2022
Same author

Reporting infectious complications in haematology clinical trials should be improved.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Immunology

Background:

  • Solid-organ transplant recipients are at high risk for infections.
  • Pretransplant screening is essential for identifying and treating existing infections.
  • Immunosuppression post-transplant further increases infection susceptibility.

Purpose of the Study:

  • To review pretransplant strategies for infection prevention in solid-organ transplant candidates.
  • To highlight the importance of immunization as a cornerstone of preventive care.
  • To discuss management of special risk groups.

Main Methods:

  • Review of pretransplant screening protocols.
  • Analysis of immunization guidelines for transplant candidates.

Related Experiment Videos

  • Discussion of specific vaccine recommendations based on transplant type and patient age.

    • Main Results:

    • Pretransplant screening detects and allows treatment of active infections.
    • Updated immunizations (pneumococcal, influenza, hepatitis B) are critical.
    • Specific vaccines like hepatitis A, Haemophilus influenzae type B conjugate, and varicella are recommended for certain groups.

    Conclusions:

    • Proactive infection prevention through screening and timely immunization significantly improves outcomes for solid-organ transplant recipients.
    • Optimizing vaccine response requires early administration before significant immunosuppression.
    • Tailored strategies for special risk groups are necessary for comprehensive care.